Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
US10239955B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2017 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Jun 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/01004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a monoclonal antibody or a fragment thereof that selectively inhibits the enzymatic activity of vascular endothelial lipase and pharmaceutical compositions containing the same as an active ingredient useful for the treatment of arteriosclerosis or metabolic syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.